Medical Oncology

4.9k papers and 85.2k indexed citations i.

About

The 4.9k papers published in Medical Oncology in the last decades have received a total of 85.2k indexed citations. Papers published in Medical Oncology usually cover Oncology (2.0k papers), Molecular Biology (2.0k papers) and Pulmonary and Respiratory Medicine (1.1k papers) specifically the topics of Lung Cancer Treatments and Mutations (274 papers), Lymphoma Diagnosis and Treatment (262 papers) and MicroRNA in disease regulation (253 papers). The most active scholars publishing in Medical Oncology are Ezzeldin M. Ibrahim, Tadashi Terada, Sameer Quazi, Oliver Thews, Peter Vaupel, Michael Hoeckel, Sandro Barni, Rainer J. Klement, Fausto Petrelli and Taxiarchis Kourelis.

In The Last Decade

Fields of papers published in Medical Oncology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Medical Oncology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Medical Oncology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Medical Oncology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Medical Oncology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025